Rouprêt M - Search Results

1

PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.

Teyssonneau D, Thiery-Vuillemin A, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Mathieu R, Sargos P, Rouprêt M, Ploussard G, Roubaud G, On Behalf Of The Cc-Afu Cancerology Committee Of The Association Française d'Urologie. Teyssonneau D, et al. Among authors: roupret m. J Clin Med. 2022 Mar 21;11(6):1734. doi: 10.3390/jcm11061734. J Clin Med. 2022. PMID: 35330059 Free PMC article. Review.

2

[Use in daily urological practice of an ultrasound device for measuring bladder volume].

Roupret M, Chartier-Kastler E, Hopirtean V, Barret E, Haertig A, Richard F. Roupret M, et al. Presse Med. 2003 May 17;32(17):776-80. Presse Med. 2003. PMID: 12856322 French.

3

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

4

Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma.

Rouprêt M, Coulet F, Azzouzi AR, Fromont G, Cussenot O. Rouprêt M, et al. BJU Int. 2005 Jul;96(1):149-51. doi: 10.1111/j.1464-410X.2005.05585.x. BJU Int. 2005. PMID: 15963139

5

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: roupret m. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

6

Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.

Rouprêt M, Fromont G, Bitker MO, Gattegno B, Vallancien G, Cussenot O. Rouprêt M, et al. Urology. 2006 May;67(5):1028-32. doi: 10.1016/j.urology.2005.11.035. Urology. 2006. PMID: 16698363

7

[Place of laparoscopic nephroureterectomy in the treatment of upper urinary tract transitional cell carcinoma].

Roupret M, Rozet F, Sanderson KM, Lesur G, Almeida D, Harmon JD, Barret E, Cathelineau X, Vallancien G. Roupret M, et al. Prog Urol. 2006 Sep;16(4):413-7. Prog Urol. 2006. PMID: 17069031 Review. French.

8

Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results.

Rouprêt M, Harmon JD, Sanderson KM, Barret E, Cathelineau X, Vallancien G, Rozet F. Rouprêt M, et al. BJU Int. 2007 Mar;99(3):623-7. doi: 10.1111/j.1464-410X.2006.06688.x. BJU Int. 2007. PMID: 17407517

9

Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.

Rouprêt M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, Vallancien G, Rozet F. Rouprêt M, et al. Urology. 2007 Apr;69(4):656-61. doi: 10.1016/j.urology.2007.01.007. Urology. 2007. PMID: 17445646

10

[Bladder cancer and neurogenic bladder].

Ruffion A, Comperat E, Roupret M, Chartier-Kastler E. Ruffion A, et al. Among authors: roupret m. Prog Urol. 2007 May;17(3):431-5. doi: 10.1016/s1166-7087(07)92342-8. Prog Urol. 2007. PMID: 17622071 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,014 results

Search Page